• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Relationship Between Infection and Nonalcoholic Fatty Liver Disease (NAFLD) in a Developing Country: A Cross-Sectional Study.发展中国家感染与非酒精性脂肪性肝病(NAFLD)的关系:一项横断面研究
Diabetes Metab Syndr Obes. 2020 Mar 2;13:619-625. doi: 10.2147/DMSO.S237866. eCollection 2020.
2
The associations among Helicobacter pylori infection, white blood cell count and nonalcoholic fatty liver disease in a large Chinese population.中国一大群人中幽门螺杆菌感染、白细胞计数与非酒精性脂肪性肝病之间的关联。
Medicine (Baltimore). 2018 Nov;97(46):e13271. doi: 10.1097/MD.0000000000013271.
3
Helicobacter pylori infection is not associated with nonalcoholic fatty liver disease.幽门螺杆菌感染与非酒精性脂肪性肝病无关。
World J Gastroenterol. 2016 Feb 28;22(8):2592-600. doi: 10.3748/wjg.v22.i8.2592.
4
Helicobacter pylori infection may increase the severity of nonalcoholic fatty liver disease via promoting liver function damage, glycometabolism, lipid metabolism, inflammatory reaction and metabolic syndrome.幽门螺杆菌感染可能通过促进肝功能损伤、糖代谢、脂代谢、炎症反应和代谢综合征来加重非酒精性脂肪性肝病的严重程度。
Eur J Gastroenterol Hepatol. 2020 Jul;32(7):857-866. doi: 10.1097/MEG.0000000000001601.
5
Is the Occurrence or Reversal of Nonalcoholic Fatty Liver Disease Associated with Long-Term Helicobacter pylori Infection among Chinese Adults? A Cohort Study.中国成年人非酒精性脂肪性肝病的发生或逆转与长期幽门螺杆菌感染有关吗?一项队列研究。
Gastroenterol Res Pract. 2021 Nov 24;2021:6696473. doi: 10.1155/2021/6696473. eCollection 2021.
6
Association Between Infection and Non-alcoholic Fatty Liver Disease, Hepatic Adipose Deposition and Stiffness in Southwest China.中国西南地区感染与非酒精性脂肪性肝病、肝脏脂肪沉积及硬度之间的关联
Front Med (Lausanne). 2021 Dec 24;8:764472. doi: 10.3389/fmed.2021.764472. eCollection 2021.
7
Helicobacter pylori and non-alcoholic fatty liver disease: A new enigma?幽门螺杆菌与非酒精性脂肪性肝病:新的谜团?
Helicobacter. 2018 Dec;23(6):e12537. doi: 10.1111/hel.12537. Epub 2018 Sep 23.
8
Relevance between Helicobacter Infection and Non-Alcoholic Fatty Liver Disease in Birjand, Iran.伊朗比尔詹德幽门螺杆菌感染与非酒精性脂肪性肝病之间的相关性
J Med Life. 2019 Apr-Jun;12(2):168-172. doi: 10.25122/jml-2019-0012.
9
Helicobacter pylori infection eradication for nonalcoholic fatty liver disease: a randomized controlled trial.幽门螺杆菌感染根除治疗非酒精性脂肪性肝病:一项随机对照试验。
Sci Rep. 2022 Nov 14;12(1):19530. doi: 10.1038/s41598-022-23746-0.
10
Impact of Infection on the Pathogenesis and Management of Nonalcoholic Fatty Liver Disease.感染对非酒精性脂肪性肝病发病机制及治疗的影响
J Clin Transl Hepatol. 2023 Jun 28;11(3):670-674. doi: 10.14218/JCTH.2022.00362. Epub 2023 Jan 19.

引用本文的文献

1
infection and association with chronic diseases: A focus on cardiovascular disease, MASLD, and type 2 diabetes.感染与慢性病的关联:聚焦心血管疾病、代谢功能障碍相关脂肪性肝病和2型糖尿病。
Metabol Open. 2025 Aug 11;27:100385. doi: 10.1016/j.metop.2025.100385. eCollection 2025 Sep.
2
Analysis between Helicobacter pylori infection and hepatobiliary diseases.幽门螺杆菌感染与肝胆疾病之间的分析
Front Cell Infect Microbiol. 2025 Mar 7;15:1477699. doi: 10.3389/fcimb.2025.1477699. eCollection 2025.
3
Causal link between dietary antioxidant vitamins intake, oxidative stress injury biomarkers and colorectal cancer: A Mendelian randomization study.饮食中抗氧化维生素摄入量、氧化应激损伤生物标志物与结直肠癌之间的因果关系:一项孟德尔随机化研究。
Medicine (Baltimore). 2025 Feb 14;104(7):e41531. doi: 10.1097/MD.0000000000041531.
4
Etiology-Dependent Microbiome Differences in Hepatocellular Carcinoma Development.肝细胞癌发生过程中病因依赖的微生物组差异
Int J Mol Sci. 2024 Dec 17;25(24):13510. doi: 10.3390/ijms252413510.
5
: Routes of Infection, Antimicrobial Resistance, and Alternative Therapies as a Means to Develop Infection Control.感染途径、抗菌药物耐药性以及作为制定感染控制手段的替代疗法
Diseases. 2024 Dec 3;12(12):311. doi: 10.3390/diseases12120311.
6
Prevalence and risk factors associated with metabolic dysfunction-associated steatohepatitis in patients with infection: A population-based study.感染患者中与代谢功能障碍相关脂肪性肝炎相关的患病率及危险因素:一项基于人群的研究。
World J Hepatol. 2024 Oct 27;16(10):1169-1176. doi: 10.4254/wjh.v16.i10.1169.
7
A review for non-antibiotic treatment of : new insight.关于非抗生素治疗的综述:新见解。
Front Microbiol. 2024 May 7;15:1379209. doi: 10.3389/fmicb.2024.1379209. eCollection 2024.
8
The Role of and Metabolic Syndrome-Related Mast Cell Activation Pathologies and Their Potential Impact on Pregnancy and Neonatal Outcomes.与代谢综合征相关的肥大细胞激活病理机制的作用及其对妊娠和新生儿结局的潜在影响。
J Clin Med. 2024 Apr 18;13(8):2360. doi: 10.3390/jcm13082360.
9
Change in Diagnosis of Infection in the Treatment-Failure Era.治疗失败时代感染诊断的变化
Antibiotics (Basel). 2024 Apr 12;13(4):357. doi: 10.3390/antibiotics13040357.
10
Does Portal Hypertension Increase the Risk of Infection and Pre-Malignant Gastric Lesions?门静脉高压会增加感染和胃癌前病变的风险吗?
J Clin Med. 2024 Mar 19;13(6):1768. doi: 10.3390/jcm13061768.

本文引用的文献

1
Helicobacter pylori infection may increase the severity of nonalcoholic fatty liver disease via promoting liver function damage, glycometabolism, lipid metabolism, inflammatory reaction and metabolic syndrome.幽门螺杆菌感染可能通过促进肝功能损伤、糖代谢、脂代谢、炎症反应和代谢综合征来加重非酒精性脂肪性肝病的严重程度。
Eur J Gastroenterol Hepatol. 2020 Jul;32(7):857-866. doi: 10.1097/MEG.0000000000001601.
2
Egyptian recommendations for management of Helicobacter pylori infection: 2018 report.《埃及幽门螺杆菌感染管理建议:2018年报告》
Arab J Gastroenterol. 2019 Sep;20(3):175-179. doi: 10.1016/j.ajg.2019.09.001. Epub 2019 Sep 26.
3
Association between Helicobacter pylori infection and risk of nonalcoholic fatty liver disease: An updated meta-analysis.幽门螺杆菌感染与非酒精性脂肪性肝病风险的关系:一项更新的荟萃分析。
Metabolism. 2019 Jul;96:56-65. doi: 10.1016/j.metabol.2019.04.012. Epub 2019 Apr 29.
4
Association between Helicobacter pylori infection and nonalcoholic fatty liver disease: a systemic review and meta-analysis.幽门螺杆菌感染与非酒精性脂肪性肝病的关系:系统评价和荟萃分析。
Eur J Gastroenterol Hepatol. 2019 Jul;31(7):735-742. doi: 10.1097/MEG.0000000000001398.
5
Helicobacter pylori infection and risk of salmonella infection.幽门螺杆菌感染与沙门氏菌感染风险
Medicine (Baltimore). 2019 Feb;98(6):e14335. doi: 10.1097/MD.0000000000014335.
6
may be an initiating factor in newly diagnosed ulcerative colitis patients: A pilot study.可能是新诊断溃疡性结肠炎患者的一个起始因素:一项初步研究。
World J Clin Cases. 2018 Nov 6;6(13):641-649. doi: 10.12998/wjcc.v6.i13.641.
7
Infection Is Not Associated with Non-alcoholic Fatty Liver Disease: A Cross-Sectional Study in China.感染与非酒精性脂肪性肝病无关:一项中国的横断面研究。
Front Microbiol. 2018 Jan 31;9:73. doi: 10.3389/fmicb.2018.00073. eCollection 2018.
8
Randomized controlled study of a novel triple nitazoxanide (NTZ)-containing therapeutic regimen versus the traditional regimen for eradication of Helicobacter pylori infection.随机对照研究新型三联硝唑(NTZ)含治疗方案与传统方案根除幽门螺杆菌感染的疗效比较。
Helicobacter. 2017 Oct;22(5). doi: 10.1111/hel.12395. Epub 2017 May 19.
9
A cohort study on Helicobacter pylori infection associated with nonalcoholic fatty liver disease.一项关于幽门螺杆菌感染与非酒精性脂肪性肝病相关性的队列研究。
J Gastroenterol. 2017 Nov;52(11):1201-1210. doi: 10.1007/s00535-017-1337-y. Epub 2017 Apr 5.
10
A 2-week Nitazoxanide-based quadruple treatment as a rescue therapy for Helicobacter pylori eradication: A single center experience.基于硝唑尼特的两周四联疗法作为幽门螺杆菌根除的挽救疗法:单中心经验
Medicine (Baltimore). 2016 Jun;95(24):e3879. doi: 10.1097/MD.0000000000003879.

发展中国家感染与非酒精性脂肪性肝病(NAFLD)的关系:一项横断面研究

Relationship Between Infection and Nonalcoholic Fatty Liver Disease (NAFLD) in a Developing Country: A Cross-Sectional Study.

作者信息

Abo-Amer Yousry Esam-Eldin, Sabal Aisha, Ahmed Rehab, Hasan Nabil Fathy Esmael, Refaie Rasha, Mostafa Sahar Mohamed, Mohamed Ahmed Abdelhaleem, Khalil Mahmoud, Elagawy Waleed, Abd-Elsalam Sherief

机构信息

Hepatology, Gastroenterology and Infectious Diseases Department, Mahala Hepatology Teaching Hospital, Gharbia, Egypt.

Hepatology, Tropical Medicine and Infectious Diseases Departments, National Hepatology and Tropical Medicine Research Institute, Cairo, Egypt.

出版信息

Diabetes Metab Syndr Obes. 2020 Mar 2;13:619-625. doi: 10.2147/DMSO.S237866. eCollection 2020.

DOI:10.2147/DMSO.S237866
PMID:32184641
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7060033/
Abstract

BACKGROUND

Non-alcoholic fatty liver disease (NAFLD) is a very common disease that affects 25-30% of the population in western countries. Many studies have observed the importance of infection in the development of insulin resistance, non-alcoholic fatty liver disease, non-alcoholic steatohepatitis, and liver fibrosis and cirrhosis. However, the evidence from different studies was controversial. The present study aimed to investigate the relationship between infection and NAFLD in a developing country.

PATIENTS AND METHODS

This cross-sectional study included all the attending outpatient clinics at four Major University hospitals and two research and clinical institutes in a developing country in the period between June and October 2019. Patients were assessed for the diagnosis of infection as detected by antigen in stool; they were also assessed for the diagnosis of NAFLD by ultrasound, fibroscan, and CAP.

RESULTS

The study was conducted on 646 patients; infection was found to be present in 538 patients (83.3%). NAFLD (diagnosed by both U/S and Fibroscan with CAP), ALT, AST, hepatomegaly, hypertension, fasting blood sugar were significantly higher in +ve group than -ve group. After performing Linear regression of independent risk factors of NAFLD to prove or to refute the role of Helicobacter; positivity, total cholesterol, degree of fatty liver by ultrasound, fasting blood sugar and diastolic blood pressure were independent risk factors for NAFLD.

CONCLUSION

infection was independent risk factors for NAFLD and correlated with increased degree of steatosis.

摘要

背景

非酒精性脂肪性肝病(NAFLD)是一种非常常见的疾病,在西方国家影响着25%-30%的人口。许多研究已经观察到感染在胰岛素抵抗、非酒精性脂肪性肝病、非酒精性脂肪性肝炎以及肝纤维化和肝硬化发展过程中的重要性。然而,不同研究的证据存在争议。本研究旨在调查在一个发展中国家感染与NAFLD之间的关系。

患者与方法

这项横断面研究纳入了2019年6月至10月期间一个发展中国家的四家主要大学医院以及两家研究和临床机构的所有门诊患者。对患者进行评估,以诊断粪便中抗原检测到的感染情况;还通过超声、肝脏硬度值测定仪和受控衰减参数(CAP)对患者进行NAFLD诊断评估。

结果

该研究共纳入646例患者;发现538例患者(83.3%)存在感染。NAFLD(通过超声和肝脏硬度值测定仪结合CAP诊断)、谷丙转氨酶(ALT)、谷草转氨酶(AST)、肝肿大、高血压、空腹血糖在阳性组显著高于阴性组。在对NAFLD的独立危险因素进行线性回归分析以证实或反驳幽门螺杆菌的作用后;幽门螺杆菌阳性、总胆固醇、超声检查的脂肪肝程度、空腹血糖和舒张压是NAFLD的独立危险因素。

结论

感染是NAFLD的独立危险因素,且与脂肪变性程度增加相关。